Cogent Biosciences Inc
NASDAQ:COGT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cogent Biosciences Inc
NASDAQ:COGT
|
US |
|
V
|
Vinci SA
XHAN:SQU
|
FR |
|
B&M European Value Retail PLC
F:7Z5
|
JE |
|
CIELO SA Instituicao de Pagamento
F:28MA
|
BR |
|
M
|
Materials Analysis Technology Inc
TPEX:3587
|
TW |
|
G-Tekt Corp
TSE:5970
|
JP |
|
S
|
Sparta AG
SWB:SPT6
|
DE |
|
B
|
Ballard Power Systems Inc
XMUN:PO0
|
CA |
|
V
|
Vipshop Holdings Ltd
F:1VPA
|
CN |
|
P
|
Pakistan Aluminium Beverage Cans Ltd
KAR:PABC
|
PK |
|
Guillemot Corporation SA
PAR:GUI
|
FR |
|
P
|
Pakistan Petroleum Ltd
KAR:PPL
|
PK |
|
B
|
Beowulf Mining PLC
XBER:B4E
|
UK |
|
S
|
Sparta AG
XMUN:SPT6
|
DE |
Bankruptcy Probability
Cogent Biosciences Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Cogent Biosciences Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Cogent Biosciences Inc
NASDAQ:COGT
|
7.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
430.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
219B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
162.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
122.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
47.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Cogent Biosciences Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Cogent Biosciences Inc has total debt of 223.2m USD. This includes both short-term (0 USD) and long-term (223.2m USD) debt.
You can find a full breakdown on its Balance Sheet.
